Document is current

Article History

Received: 11 April 2024

Accepted: 24 June 2024

First Online: 12 July 2024

Disclosure

: J.C.B. reports institutional research grant from Eli Lilly and SimBioSys; royalties from UpToDate; honoraria from EndoMag, PER, PeerView, and OncLive; received travel support from EndoMag and Alliance for Clinical Trials in Oncology; is a member of DSMC for Cairns Surgical; serves on board of directors for ASBS; and is an unpaid working group Chair at Society of Surgical Oncology Breast Disease Site. C.Y. reports institutional research grant from NCI/NIH; salary and travel support from Quantum Leap Healthcare Collaborative (QLHC); University of California Inventor Share; and patent “Breast cancer response prediction subtypes” (no. 18/174,491). M.G. reports funding from the Breast Cancer Research Foundation. M.P. reports institutional research funding and travel support from Intuitive Surgical; honoraria from Kubtec Medical Imaging and OncLive; participation on DSMB at Mayo Clinic; and co-development contract with Optiscan. M.H.M. reports roles on the SSO Development Committee and ASBrS Scientific Committee. M.C.L. reports institutional research grant and honoraria from Elucent Medical; participation on the Provepharm Advisory Board; and owns stock in J&J. S.F. reports consulting fees from Stryker and institutional equipment support from Montefiore. I.G. reports consulting fees from Abbvie and honoraria from OncLive/MJH Life Sciences. K.H. reports publishing royalties from UpToDate and participation in the QLHC DSMB. C.S. reports participation on the Executive Committee for AJCC. L.J.E. reports institutional research funding from Moderna for DCIS trial; publishing royalties from UpToDate; and travel support from and participation on Medical Advisory Board at Blue Cross Blue Shield. R.M. reports research support and honoraria from GE Healthcare and NCI; institutional research funding from UCSF; and is an unpaid member of the Scientific Advisory Board for the Lobular Breast Cancer Alliance. C.R. reports previous consultant for Elucent Medical (localizing device), terminated association 12/2022, and consultant for agenda, terminated 12/2022. J.T. reports institutional primary investigator on clinical trial for Intuitive Surgical.